NICE LTD - SPON ADR (NICE) Stock Fundamental Analysis

NASDAQ:NICE • US6536561086

103.55 USD
-2.14 (-2.02%)
At close: Feb 13, 2026
103.55 USD
0 (0%)
After Hours: 2/13/2026, 8:00:01 PM
Fundamental Rating

6

Taking everything into account, NICE scores 6 out of 10 in our fundamental rating. NICE was compared to 276 industry peers in the Software industry. While NICE has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on NICE. With these ratings, NICE could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year NICE was profitable.
  • NICE had a positive operating cash flow in the past year.
  • Each year in the past 5 years NICE has been profitable.
  • NICE had a positive operating cash flow in each of the past 5 years.
NICE Yearly Net Income VS EBIT VS OCF VS FCFNICE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of NICE (10.83%) is better than 85.87% of its industry peers.
  • NICE has a Return On Equity of 14.45%. This is amongst the best in the industry. NICE outperforms 80.80% of its industry peers.
  • The Return On Invested Capital of NICE (11.19%) is better than 86.59% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NICE is below the industry average of 10.74%.
  • The 3 year average ROIC (8.49%) for NICE is below the current ROIC(11.19%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.83%
ROE 14.45%
ROIC 11.19%
ROA(3y)6.78%
ROA(5y)5.84%
ROE(3y)10.34%
ROE(5y)9.15%
ROIC(3y)8.49%
ROIC(5y)7.35%
NICE Yearly ROA, ROE, ROICNICE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • NICE has a better Profit Margin (19.37%) than 82.97% of its industry peers.
  • In the last couple of years the Profit Margin of NICE has grown nicely.
  • The Operating Margin of NICE (22.02%) is better than 87.32% of its industry peers.
  • NICE's Operating Margin has improved in the last couple of years.
  • NICE has a Gross Margin (67.05%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NICE has remained more or less at the same level.
Industry RankSector Rank
OM 22.02%
PM (TTM) 19.37%
GM 67.05%
OM growth 3Y13.23%
OM growth 5Y5.7%
PM growth 3Y15.65%
PM growth 5Y6.35%
GM growth 3Y-0.37%
GM growth 5Y0.16%
NICE Yearly Profit, Operating, Gross MarginsNICE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

  • NICE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for NICE has been increased compared to 1 year ago.
  • NICE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, NICE has an improved debt to assets ratio.
NICE Yearly Shares OutstandingNICE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NICE Yearly Total Debt VS Total AssetsNICE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • There is no outstanding debt for NICE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.28
WACC8.74%
NICE Yearly LT Debt VS Equity VS FCFNICE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.41 indicates that NICE should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.41, NICE perfoms like the industry average, outperforming 43.84% of the companies in the same industry.
  • NICE has a Quick Ratio of 1.41. This is a normal value and indicates that NICE is financially healthy and should not expect problems in meeting its short term obligations.
  • NICE has a Quick ratio (1.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
NICE Yearly Current Assets VS Current LiabilitesNICE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.49% over the past year.
  • NICE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.93% yearly.
  • NICE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.24%.
  • Measured over the past years, NICE shows a quite strong growth in Revenue. The Revenue has been growing by 11.69% on average per year.
EPS 1Y (TTM)15.49%
EPS 3Y19.48%
EPS 5Y15.93%
EPS Q2Q%10.42%
Revenue 1Y (TTM)9.24%
Revenue growth 3Y12.5%
Revenue growth 5Y11.69%
Sales Q2Q%6.09%

3.2 Future

  • Based on estimates for the next years, NICE will show a small growth in Earnings Per Share. The EPS will grow by 4.79% on average per year.
  • NICE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y12.48%
EPS Next 2Y1.66%
EPS Next 3Y4.79%
EPS Next 5YN/A
Revenue Next Year7.61%
Revenue Next 2Y7.84%
Revenue Next 3Y8.47%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NICE Yearly Revenue VS EstimatesNICE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
NICE Yearly EPS VS EstimatesNICE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

9

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.38, which indicates a very decent valuation of NICE.
  • NICE's Price/Earnings ratio is rather cheap when compared to the industry. NICE is cheaper than 90.94% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of NICE to the average of the S&P500 Index (27.19), we can say NICE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 8.81, the valuation of NICE can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, NICE is valued cheaply inside the industry as 87.32% of the companies are valued more expensively.
  • NICE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 8.38
Fwd PE 8.81
NICE Price Earnings VS Forward Price EarningsNICE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NICE is valued cheaper than 91.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, NICE is valued cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.24
EV/EBITDA 7.19
NICE Per share dataNICE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NICE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.67
PEG (5Y)0.53
EPS Next 2Y1.66%
EPS Next 3Y4.79%

0

5. Dividend

5.1 Amount

  • NICE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NICE LTD - SPON ADR

NASDAQ:NICE (2/13/2026, 8:00:01 PM)

After market: 103.55 0 (0%)

103.55

-2.14 (-2.02%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13
Earnings (Next)02-19
Inst Owners12.79%
Inst Owner Change-5.44%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.39B
Revenue(TTM)2.88B
Net Income(TTM)557.97M
Analysts77.5
Price Target206.79 (99.7%)
Short Float %3.9%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.64%
Min EPS beat(2)-1.87%
Max EPS beat(2)-1.41%
EPS beat(4)0
Avg EPS beat(4)-1.13%
Min EPS beat(4)-1.87%
Max EPS beat(4)-0.07%
EPS beat(8)4
Avg EPS beat(8)0.76%
EPS beat(12)8
Avg EPS beat(12)1.33%
EPS beat(16)11
Avg EPS beat(16)1.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.48%
Max Revenue beat(2)-0.14%
Revenue beat(4)0
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.14%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)0
Avg Revenue beat(12)-1.29%
Revenue beat(16)2
Avg Revenue beat(16)-0.83%
PT rev (1m)3.24%
PT rev (3m)5.26%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)-5.61%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-1.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 8.38
Fwd PE 8.81
P/S 2.22
P/FCF 9.24
P/OCF 8.13
P/B 1.66
P/tB 8.01
EV/EBITDA 7.19
EPS(TTM)12.36
EY11.94%
EPS(NY)11.76
Fwd EY11.35%
FCF(TTM)11.21
FCFY10.82%
OCF(TTM)12.74
OCFY12.3%
SpS46.65
BVpS62.53
TBVpS12.93
PEG (NY)0.67
PEG (5Y)0.53
Graham Number131.87
Profitability
Industry RankSector Rank
ROA 10.83%
ROE 14.45%
ROCE 15.21%
ROIC 11.19%
ROICexc 12.56%
ROICexgc 71.45%
OM 22.02%
PM (TTM) 19.37%
GM 67.05%
FCFM 24.02%
ROA(3y)6.78%
ROA(5y)5.84%
ROE(3y)10.34%
ROE(5y)9.15%
ROIC(3y)8.49%
ROIC(5y)7.35%
ROICexc(3y)14.21%
ROICexc(5y)12.54%
ROICexgc(3y)163.28%
ROICexgc(5y)N/A
ROCE(3y)11.55%
ROCE(5y)10%
ROICexgc growth 3Y25.64%
ROICexgc growth 5Y53.44%
ROICexc growth 3Y23.73%
ROICexc growth 5Y18.38%
OM growth 3Y13.23%
OM growth 5Y5.7%
PM growth 3Y15.65%
PM growth 5Y6.35%
GM growth 3Y-0.37%
GM growth 5Y0.16%
F-Score8
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 50.85%
Cap/Sales 3.28%
Interest Coverage 250
Cash Conversion 95.89%
Profit Quality 124.01%
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z N/A
F-Score8
WACC8.74%
ROIC/WACC1.28
Cap/Depr(3y)48.45%
Cap/Depr(5y)43.32%
Cap/Sales(3y)3.65%
Cap/Sales(5y)3.66%
Profit Quality(3y)152.88%
Profit Quality(5y)173.68%
High Growth Momentum
Growth
EPS 1Y (TTM)15.49%
EPS 3Y19.48%
EPS 5Y15.93%
EPS Q2Q%10.42%
EPS Next Y12.48%
EPS Next 2Y1.66%
EPS Next 3Y4.79%
EPS Next 5YN/A
Revenue 1Y (TTM)9.24%
Revenue growth 3Y12.5%
Revenue growth 5Y11.69%
Sales Q2Q%6.09%
Revenue Next Year7.61%
Revenue Next 2Y7.84%
Revenue Next 3Y8.47%
Revenue Next 5YN/A
EBIT growth 1Y20%
EBIT growth 3Y27.38%
EBIT growth 5Y18.06%
EBIT Next Year19.23%
EBIT Next 3Y5.28%
EBIT Next 5YN/A
FCF growth 1Y47.34%
FCF growth 3Y22.92%
FCF growth 5Y18.61%
OCF growth 1Y41.03%
OCF growth 3Y21.71%
OCF growth 5Y17.35%

NICE LTD - SPON ADR / NICE FAQ

What is the ChartMill fundamental rating of NICE LTD - SPON ADR (NICE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to NICE.


Can you provide the valuation status for NICE LTD - SPON ADR?

ChartMill assigns a valuation rating of 9 / 10 to NICE LTD - SPON ADR (NICE). This can be considered as Undervalued.


Can you provide the profitability details for NICE LTD - SPON ADR?

NICE LTD - SPON ADR (NICE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for NICE stock?

The Price/Earnings (PE) ratio for NICE LTD - SPON ADR (NICE) is 8.38 and the Price/Book (PB) ratio is 1.66.


What is the financial health of NICE LTD - SPON ADR (NICE) stock?

The financial health rating of NICE LTD - SPON ADR (NICE) is 5 / 10.